Welcome to our dedicated page for Sgs SA news (Ticker: SGSOY), a resource for investors and traders seeking the latest updates and insights on Sgs SA stock.
News for SGS SA ADR (SGSOY) reflects developments at SGS SA, which describes itself as the world's leading testing, inspection and certification company. Updates often highlight how SGS expands or enhances its laboratory capabilities, adopts recognized standards and supports clients in regulated industries such as cosmetics, hygiene and personal care.
One example of the type of news investors and observers may see is the announcement of ISO 17025 accreditation for an SGS laboratory in Phoenix, Arizona. This facility specializes in in-vivo and in-vitro testing for qualitative and quantitative analysis of cosmetics, handwashes, hand sanitizers and other handwashing agents. Such news illustrates how SGS aligns its operations with key standards and responds to demand for antimicrobial testing and quality assurance.
Coverage can include items related to laboratory accreditations, the adoption of specific test methods such as ASTM 1174, ASTM 2755, USP 61 and USP 62, and initiatives tied to corporate strategies in regions like North America. Articles may also describe how SGS supports manufacturers and retailers in bringing products such as cosmetics, household products and disinfectants to store shelves under evolving regulatory requirements.
By following SGSOY news, readers can monitor how SGS presents its role in the testing, inspection and certification industry, including developments in its global lab network, quality assurance services and specialized brands such as Brightsight, Bluesign, Maine Pointe and Nutrasource. This page offers a focused view of company announcements and related information relevant to SGS SA and its ADR.
SGS (SGSOY) has received ISO 17025 accreditation for its Mississauga laboratory, enabling it to offer extractables and leachables (E&L) testing services in Canada. The facility, specializing in biologics, chemistry, and microbiological testing, serves pharmaceutical, biopharmaceutical, and medical device manufacturers across North America. Located near Toronto, where over 50% of Canada's pharmaceutical companies are based, this expansion increases SGS's E&L testing capacity in North America, complementing its existing facility in Fairfield, New Jersey.
The Mississauga laboratory holds multiple certifications including Health Canada and FDA registration, GMP certification, ISO 9001:2015, and ISO 13485:2016. SGS operates 20 laboratories across 11 countries, offering comprehensive testing services and clinical trial management for both large pharmaceutical companies and smaller manufacturers.
SGS (SGSOY) has achieved ISO 17025 accreditation for its Phoenix, Arizona laboratory specializing in in-vivo and in-vitro testing of cosmetics, handwashes, and hand sanitizers. This marks the first such accreditation for an SGS U.S.-based lab focused on handwash testing.
The laboratory conducts qualitative and quantitative analysis to determine anti-microbial effectiveness against viruses and bacteria, using methods including ASTM 1174, ASTM 2755, USP 61, and USP 62. The accreditation aligns with SGS's Strategy 27, which targets growth in North America and responds to increased market demand for quality assurance.
The facility supports manufacturers and retailers in the cosmetics, hygiene, and personal care industries with testing solutions and regulatory compliance guidance, leveraging SGS's 40+ years of research experience in the sector.